Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

535.27

+19.93 (3.87%)

At close: Aug 11, 2026, 4:00 PM EDT

539.00

+3.73 (0.70%)

Pre-market: Aug 12, 2026, 9:15 AM EDT

Madrigal Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	-325.1	-288.28	-465.89	-373.63	-295.35	-241.85
Depreciation & Amortization	1.52	1.51	1.1	0.53	0.47	0.41
Stock-Based Compensation	121.43	98.13	79.88	49.74	31.63	26.87
Other Adjustments	3.03	7.59	2.09	2.41	0.8	-
Change in Receivables	-113.08	-80.65	-53.82	-	-	-
Changes in Inventories	-41.2	-36.98	-34.07	-	-	-
Changes in Accounts Payable	-6.65	5.28	15.56	4.21	2.45	20.36
Changes in Accrued Expenses	174.66	131.9	34.72	-1.48	36.41	9.83
Changes in Other Operating Activities	-25.56	-28.05	-34.73	-6.01	-1.26	0.46
Operating Cash Flow	-197.72	-189.55	-455.57	-324.23	-224.86	-183.92
Operating Cash Flow Growth	-	-	-	-	-	-

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Capital Expenditures	-8.57	-0.47	-1.46	-1.48	-0.22	-0.21
Purchases of Intangible Assets	-	-3	-5	-	-	-
Purchases of Investments	-997.84	-1,048	-1,131	-834.44	-143.48	-394.12
Proceeds from Sale of Investments	1,056	1,083	863.28	333.4	350.38	389.27
Investing Cash Flow	46.97	32.32	-274.39	-502.52	206.69	-5.06

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Long-Term Debt Issued	-	350	-	65	50	-
Long-Term Debt Repaid	-	-121.66	-	-	-	-
Net Long-Term Debt Issued (Repaid)	-	228.34	-	65	50	-
Issuance of Common Stock	-4.94	38.06	735.06	530.48	264.34	171.24
Net Common Stock Issued (Repurchased)	-4.94	38.06	735.06	530.48	264.34	171.24
Other Financing Activities	-	-10.41	-	-0.36	-0.89	-
Financing Cash Flow	251.04	255.98	735.06	595.12	313.45	171.24

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Foreign Exchange Rate Adjustments	1.39	0.01	-	-	-	-
Net Cash Flow	101.69	98.76	5.1	-231.63	295.28	-17.74

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Free Cash Flow	-206.29	-190.02	-457.03	-325.71	-225.07	-184.13
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-16.07%	-19.83%	-253.72%	-	-	-
Free Cash Flow Per Share	-7.53	-8.47	-21.48	-17.43	-13.13	-11.14
Levered Free Cash Flow	-230.9	13.25	-484.78	-312.86	-207.5	-211
Unlevered Free Cash Flow	-228.42	-226.9	-516.76	-384.72	-255.72	-211.64

SEC Filings: 10-K · 10-Q